Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07104162 · ClinicalTrials.gov registry record · Phase 1

A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment

A Phase 1 study of Bacterial Infections, sponsored by Qpex Biopharma.

Recruiting
Registry status
Phase 1
Development phase
40
Enrollment target
2
Study locations

NCT07104162 is a Phase 1 study of Bacterial Infections that is actively recruiting participants, run by Qpex Biopharma. The registered enrollment target is 40 participants, below the 139-participant average among 17 other Bacterial Infections trials with a reported enrollment target (71% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07104162, a Phase 1 study of Bacterial Infections, is actively recruiting participants, sponsored by Qpex Biopharma.

RECRUITING
Registry status
Phase 1
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

A Phase 1, Open-label, Single-dose Study to Determine the Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam (S-649228) in Participants with Renal Impairment

Conditions Studied

Bacterial Infections

Interventions

  • DRUG Cefiderocol/Xeruborbactam

Study Locations (2)

Florida

  • University of Miami Clinical Pharmacology - Miami
  • Orlando Clinical Research Center - Orlando

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-09-16
Est. Completion 2026-12-23
Phase Phase 1

Sponsor

Qpex Biopharma

7 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07104162

The ClinicalTrials.gov registry entry for NCT07104162 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 139-participant average among 17 other Bacterial Infections trials with a reported enrollment target (71% lower). The listed sponsor is Qpex Biopharma, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Bacterial Infections appearing as the primary indexed condition, and to 1 intervention - of which Cefiderocol/Xeruborbactam is the first listed.

NCT07104162 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT07104162 about?

NCT07104162 is a clinical study titled "A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment". A Phase 1, Open-label, Single-dose Study to Determine the Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam (S-649228) in Participants with Renal Impairment

What is the current status of trial NCT07104162?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2025-09-16. Estimated completion is 2026-12-23.

What conditions does trial NCT07104162 study?

This clinical trial studies the following conditions: Bacterial Infections.

What interventions are being tested in trial NCT07104162?

The interventions under investigation include: Cefiderocol/Xeruborbactam (DRUG).

Who is sponsoring clinical trial NCT07104162?

This trial is sponsored by Qpex Biopharma, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07104162 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Bacterial Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Bacterial Infections

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.